doxycycline hyclate 50 MG Oral Tablet [Targadox]
- RxCUI
- 1806948
- RxNorm name
- doxycycline hyclate 50 MG Oral Tablet [Targadox]
- Display name
- TARGADOX (Oral Pill)
- Full name
- doxycycline hyclate 50 MG Oral Tablet [Targadox]
- Term type
- SBD
- Status
- Active
- Strength
- 50 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-11-12 18:37:33
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102016
- Active start
- 102016
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| doxycycline hyclate | 50 MG / 1 EACH | doxycycline | doxycycline |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| doxycycline | 3640 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Targadox 50 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | doxycycline hyclate 50 MG Oral Tablet [Targadox] | 1 | NAMES |
| RxNorm Synonym | Targadox 50 MG Oral Tablet | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 83243f78-b984-46a4-a88a-c6a15c217b90 | 1 | CODES |
| RxCUI | 1806948 | 1 | CODES |
| MMSL_CODE | BD13064 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 69489-111-05 | 69489-111 | TARGADOX doxycycline hyclate | Journey Medical Corporation | ANDA062269 |
| 69489-111-60 | 69489-111 | TARGADOX doxycycline hyclate | Journey Medical Corporation | ANDA062269 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA062269 | 69489-111 | TARGADOX doxycycline hyclate | ANDA | Journey Medical Corporation |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TARGADOX | DOXYCYCLINE HYCLATE | Journey Medical Corporation | 83243f78-b984-46a4-a88a-c6a15c217b90 | 2025-10-21 | Warnings, Adverse reactions | 69489-111-60 69489-111-05 69489-111 69489011105 69489011160 1806948 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 83243f78-b984-46a4-a88a-c6a15c217b90 | TargaDOX 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [Targadox] [SBD] · Targadox 50 MG Oral Tablet [SY] | 3 | 7 | TARGADOX ® (doxycycline hyclate USP) 50 mg tablets | 20251021 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 83243f78-b984-46a4-a88a-c6a15c217b90 | TARGADOX ® (doxycycline hyclate USP) 50 mg tablets | Journey Medical Corporation | 20251021 |
| 83243f78-b984-46a4-a88a-c6a15c217b90 | TARGADOX ® ( doxycycline hyclate USP ) 50 mg tablets | Journey Medical Corporation | Caribe Holdings (Cayman) Co. Ltd. dba PuraCap Caribe | 20200731 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A01AB | Antiinfectives and antiseptics for local oral treatment | ATC1-4 | doxycycline | |
| ATC | J01AA | Tetracyclines | ATC1-4 | doxycycline | |
| FDASPL | D013754 | Tetracyclines | CHEM | has_chemical_structure | doxycycline |
| FDASPL | N0000175882 | Tetracycline-class Drug | EPC | has_epc | doxycycline |
| MEDRT | D004318 | Doxycycline | CHEM | has_ingredient | doxycycline hyclate |
| MEDRT | D004318 | Doxycycline | CHEM | has_ingredient | doxycycline |
| MEDRT | D013752 | Tetracycline | CHEM | ci_chemclass | doxycycline |
| MEDRT | D013752 | Tetracycline | CHEM | ci_chemclass | doxycycline hyclate |
| MEDRT | D000881 | Anthrax | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D000881 | Anthrax | DISEASE | may_treat | doxycycline |
| MEDRT | D002169 | Campylobacter Infections | DISEASE | may_treat | doxycycline |
| MEDRT | D002169 | Campylobacter Infections | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | doxycycline |
| MEDRT | D002771 | Cholera | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D002771 | Cholera | DISEASE | may_treat | doxycycline |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | doxycycline |
| MEDRT | D006100 | Granuloma Inguinale | DISEASE | may_treat | doxycycline |
| MEDRT | D006100 | Granuloma Inguinale | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | doxycycline |
| MEDRT | D008288 | Malaria | DISEASE | may_prevent | doxycycline |
| MEDRT | D008288 | Malaria | DISEASE | may_prevent | doxycycline hyclate |
| MEDRT | D009175 | Mycoplasma Infections | DISEASE | may_treat | doxycycline |
| MEDRT | D009175 | Mycoplasma Infections | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D010930 | Plague | DISEASE | may_treat | doxycycline |
| MEDRT | D010930 | Plague | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D010996 | Pleural Effusion | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D010996 | Pleural Effusion | DISEASE | may_treat | doxycycline |
| MEDRT | D018410 | Pneumonia, Bacterial | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D018410 | Pneumonia, Bacterial | DISEASE | may_treat | doxycycline |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | doxycycline |
| MEDRT | D009956 | Psittacosis | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D009956 | Psittacosis | DISEASE | may_treat | doxycycline |
| MEDRT | D012061 | Relapsing Fever | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D012061 | Relapsing Fever | DISEASE | may_treat | doxycycline |
| MEDRT | D012373 | Rocky Mountain Spotted Fever | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D012373 | Rocky Mountain Spotted Fever | DISEASE | may_treat | doxycycline |
| MEDRT | D012598 | Sclerosis | DISEASE | induces | doxycycline |
| MEDRT | D012598 | Sclerosis | DISEASE | induces | doxycycline hyclate |
| MEDRT | D013587 | Syphilis | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D013587 | Syphilis | DISEASE | may_treat | doxycycline |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | doxycycline |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | doxycycline hyclate |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | doxycycline |
| MEDRT | N0000008334 | Cell Membrane Alteration | PE | has_pe | doxycycline hyclate |
| MEDRT | N0000008334 | Cell Membrane Alteration | PE | has_pe | doxycycline |
| MEDRT | N0000008732 | Decreased Mitosis | PE | has_pe | doxycycline hyclate |
| MEDRT | N0000008732 | Decreased Mitosis | PE | has_pe | doxycycline |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | doxycycline hyclate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | doxycycline |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 50 MG (expressed as doxycycline hyclate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA062269 |
| NAMES | Prescribable Synonym | TargaDOX 50 MG Oral Tablet |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |